moderate pregnancy-induced hypertension (blood pressure 160/105 mmHg) and 1 + proteinuria on urinalysis. Antenatal assessments had been hitherto normal. She was treated with intravenous hydralazine without success. Methyldopa was added to her therapy, but her blood pressure remained elevated and proteinuria deteriorated to 2+. On the third hospital day, the patient became severely breathless over a period of four hours. On examination, she was moderately distressed and tachpnoeic (34 beats/min) and had a gallop rhythm with diffuse fine inspiratory crackles in both lung bases Pregnancy-induced hypertension. QUESTION 3 The first line treatment is intravenous frusemide 40 mg or bumetanide 1 mg as a bolus dose. The aim is to achieve a diuresis of2-3 1 in the first 24 hours of diuretic therapy. A Swan-Ganz catheter is desirable in severe pre-eclamptic patients who develop pulmonary oedema antepartum. This allows the clinician to differentiate between fluid overload, left ventricular dysfunction and non-hydrostatic pulmonary oedema, the management of each being different.
Right atrial pressure (16 cmH2O), pulmonary artery pressure (42/16 mmHg) and pulmonary capillary wedge pressure (PCWP; 24 mmHg) were all raised in this case. The serum albumin concentration dropped to a nadir of 27 g/l (total protein 52 g/l) and the plasma colloid oncotic pressure (COP) was calculated as 18.9 mmHg (normally approximately 25 mmHg). Thus, a lowered plasma oncotic pressure and a raised PCWP both contributed to pulmonary interstitial fluid accumulation and eventually pulmonary oedema. PCWP was reduced by a combination of intravenous frusemide and isosorbide dinitrate infusion. COP may be increased by infusing 200 ml of 20% albumin after achieving a satisfactory diuresis. The intravenous frusemide and dinitrate helped reduced systemic arterial blood pressure and reverse pulmonary oedema sufficient to proceed to emergency caesarian section, which is the most important measure in resolving the pregnancyinduced hypertension.
The patient was delivered of a live, but low birth weight infant (2.2 kg) without signs of neonatal distress. Postoperatively, the patient's blood pressure and PCWP settled to normal levels within 24 hours with the isosorbide dinitrate infusion, which was continued for 48 hours after delivery. The diastolic blood pressure became elevated again (100-110 mmHg) after stopping the dinitrate infusion and the patient was treated with oral slowrelease nifedipine 20 mg bid. This therapy was gradually reduced and eventually stopped after three weeks. QUESTION 4 The prognosis is generally excellent with prompt diuretic therapy and delivery, once the pulmonary oedema is controlled.
Discussion
Unexpected acute pulmonary oedema in pregnant women is uncommon and often generates suspicions of undiagnosed valvular heart disease, acute pulmonary embolism, thyrotoxic heart failure and peripartum cardiomyopathy. positive balance with tocolytics is independent ofconcurrently administered betamethasone or dexamthasone (to prevent foetal respiratory distress syndrome).
Sabai et al reported pulmonary oedema in 2.9% of a series of almost 1300 women with severe pre-eclampsia-eclampsia,3 nearly 75% of whom developed pulmonary oedema postpartum. In this series, patients with pulmonary oedema caused by pregnancy-induced hypertension were generally older multigravidas and more likely to have had long-standing hypertension. The pathophysiology of pulmonary oedema resulting from pregnancyinduced hypertension is not completely understood, but studies by Cotton et at4 and Benedetti et aF have noted abnormal COP-PCWP gradients in patients developing pulmonary oedema caused by pregnancyinduced hypertension. Benedetti et al, described 10 patients with this condition, five of whom had abnormal COP-PCWP gradients. Among the other five patients, pulmonary oedema was related to increased pulmonary capillary permeability in three, and left ventricular failure in two. We calculated the COP to be 18.9 mmHg in our patient.6 Given that the PCWP (24 mmHg) exceeded this level of COP, it is likely that the reduced plasma albumin level, in addition to the raised afterload caused by the increased systemic vascular resistance Cardiovascular causes of acute pulmonary oedema in late pregnancy * rheumatic valvular heart disease * congenital heart disease * pregnancy-induced hypertension * peripartum cardiomyopathy * hypertensive heart failure * thyrotoxic heart failure * beta-agonist tocolytic therapy (as reflected by the marked diastolic hypertension), both contributed significantly to the development of pulmonary oedema. Cotton et alf recommend a nitrate infusion in addition to conventional intravenous doses of frusemide to treat pulmonary oedema caused by pregnancyinduced hypertension. Afterload reduction with hydralazine or sodium nitroprusside may be necessary if intravenous boluses of frusemide and nitrate infusion are ineffective.
It is not clear from the literature whether albumin infusion has a role in the management of pulmonary oedema related to pregnancyinduced hypertension. However, where patients manifest heavy proteinuria as in this case, and where the COP-PCWP gradient can be clearly shown to be negative, it seems reasonable to correct hypoalbuminaemia, particularly levels less than 30 g/l. The infusion of 200 ml of 20% albumin in this patient coincided with intravenous frusemide boluses and isosorbide dinitrate infusion. Thus, it is not certain to what degree albumin infusion may have helped improve the pulmonary oedema. Further experience of managing this condition will no doubt clarify this point.
Final diagnosis
Pregnancy-induced hypertension resulting in acute pulmonary oedema.
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